You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 19, May 16, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Iron Reduction and Cardiovascular Outcomes

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Zacharski and colleagues1 reported no significant association between reduction of iron stores by phlebotomy and all-cause mortality, or death plus nonfatal myocardial infarction and stroke, the primary and secondary end points of the study, respectively. In post hoc analyses, they found that age significantly interacted with their primary and secondary end points and concluded that "iron reduction appeared to improve outcome to a significantly greater extent in younger compared with older patients."

The stated conclusions of the post hoc analyses were misleading. Analysis by age was not described in the initial study plan, the study was not sufficiently powered for an analysis by subgroups, and potential confounders of this seeming age effect were not included in the analysis. Great care should always be taken in interpreting and reporting subgroup analyses that are not part of the initial study design, particularly if they are used to make . . . [Full Text of this Article]

Robert D. Allison, MD, MPH
allisonr@mail.nih.gov

Barbara J. Bryant, MD; Sumithira Vasu, MD; Susan F. Leitman, MD
Department of Transfusion Medicine
Warren G. Magnuson Clinical Research Center
National Institutes of Health
Bethesda, Md


RELATED LETTERS

Iron Reduction and Cardiovascular Outcomes
Jerome L. Sullivan and Stuart D. Katz
JAMA. 2007;297(19):2075.
EXTRACT | FULL TEXT  

Iron Reduction and Cardiovascular Outcomes—Reply
Leo R. Zacharski and Bruce K. Chow
JAMA. 2007;297(19):2076.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial
Leo R. Zacharski, Bruce K. Chow, Paula S. Howes, Galina Shamayeva, John A. Baron, Ronald L. Dalman, David J. Malenka, C. Keith Ozaki, and Philip W. Lavori
JAMA. 2007;297(6):603-610.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.